HB 684 requires health insurance companies to notify members 60 days in advance if a provider (including primary care or behavioral health providers) is removed from their network, unless termination relates to fraud, abuse, or licensure issues. It mandates that members affected by such changes receive a 90-day special enrollment period to continue seeing those providers, along with clear contact information for filing complaints. Insurance companies must also notify the Maryland Insurance Commissioner about network changes at least 60 days before termination and update their access plans within 5 business days of the change. This bill directly affects health insurance members who lose provider access and requires insurers to follow specific transparency and transition procedures.
HB 671 requires Maryland's Governor to allocate at least 3% of funds collected from a Medicaid quality assessment on qualifying nursing facilities (45+ beds operating in the state) to fund the Office of the Long-Term Care Ombudsman starting in fiscal year 2027. This directly affects nursing facilities that pay the assessment and ensures dedicated, supplemental funding for the Ombudsman office, which advocates for residents' rights in long-term care settings. The bill updates existing law to mandate this specific allocation from the assessment pool, specifying that these funds must be "in addition to" and not replace existing Ombudsman funding. It does not change the assessment rate (capped at 6% of facility revenue) or the reporting requirements for the Department.
This bill establishes the Maryland Advanced Manufacturing Grant Program within the Maryland Technology Development Corporation to support companies specializing in regenerative medicine and other advanced manufacturing sectors. The program will provide grants that recipients can use exclusively for acquiring or renovating manufacturing space, improving infrastructure, and purchasing necessary equipment. A dedicated fund will be created to hold grant money, with interest earnings credited back to the fund rather than the state's general fund. The Corporation will work with the Maryland Stem Cell Research Commission to set eligibility criteria, application procedures, and award amounts, with the program taking effect on July 1, 2026.
HB 1420 requires criminal history background checks for applicants and renewing licensees in specific healthcare professions, including nursing, dentistry, pharmacy, and others listed in the bill. Starting July 1, 2027, new applicants must submit fingerprints and pay fees to the state’s Central Repository for a criminal records check under new Section 1A-302.1. Existing licensees renewing after January 1, 2028, must also provide proof of a criminal check. The bill establishes standardized procedures for conducting these checks while ensuring confidentiality and allowing applicants to contest results.
HB 423 requires Prince George’s County public high schools to provide free drink spiking detection products (for GHB/ketamine) and fentanyl detection strips to all students starting the 2026-2027 school year. These products must be available at no cost in school health clinics or libraries. Each school must also report annually (by October 1) to Maryland’s Office of Overdose Response the quantity distributed during the prior school year. The bill applies exclusively to Prince George’s County schools and takes effect July 1, 2026.
SB 792 requires the State Health Services Cost Review Commission to create and publish a model policy for hospitals regarding immigration enforcement actions. It also mandates that certain hospitals in Maryland develop their own policies based on this model. The bill amends specific sections of Maryland's health code to implement these requirements, focusing on standardizing how hospitals address immigration enforcement within their facilities. This directly affects designated hospitals by making written policies on immigration enforcement a formal requirement.
SB 742, the "Maryland Protecting People With Disabilities Act," modifies Maryland’s Medicaid eligibility processes to better protect individuals with disabilities who receive home- and community-based services. It extends the appeal timeframe for those losing eligibility and requires services to continue uninterrupted during appeals, preventing administrative errors from causing abrupt service loss. The bill prohibits "procedural disenrollment" (terminating coverage due to renewal process issues) and mandates the Department of Health to reserve waiver slots for people who lost eligibility unfairly. These changes align with the Olmstead decision, ensuring individuals can remain in community settings without unnecessary bureaucratic barriers. The bill directly affects Maryland Medicaid recipients with disabilities who rely on home- and community-based services.
HB 1284 allows residential service agencies providing private duty nursing to hire licensed nurses who lack full clinical experience requirements, under specific conditions. Agencies must provide approved on-site training programs, ensure clinical supervision by a qualified registered nurse, and conduct documented competency evaluations for these nurses. The bill requires agencies to maintain records of training completion and annual or disciplinary competency assessments. This directly affects private duty nursing agencies and nurses who may not meet standard clinical experience thresholds, while maintaining existing licensing and scope-of-practice standards.
HB 1377 establishes a 18-month pilot program to redirect unused, unopened prescription drugs to a state repository program. It requires participating pharmacies (repositories) to collect eligible medications during National Prescription Drug Take Back Days, package them properly, and transfer them to designated drop-off sites for distribution to eligible patients - while sending controlled substances directly to the DEA. The program aims to expand medication access for underserved communities, reduce pharmaceutical waste, and ensure drug safety through collaboration between Maryland’s Secretary of Health and the federal DEA. The pilot runs from July 2026 through December 2027, with mandatory reporting on collected medications by October 1, 2027.
HB 1376 requires Maryland's Medicaid (Maryland Medical Assistance Program) and Children's Health Program to provide a review within 3 business days for transfer requests to special pediatric hospitals when requested by the hospital or referring provider. It mandates retrospective reviews if a transfer is denied as "not medically necessary," with providers reimbursed for "administrative days" (days a patient remains without transfer) during the review process. The bill directly affects special pediatric hospitals - facilities serving children under 22 or those 2+ years old with co-occurring physical/behavioral health conditions - and their referring providers. Key provisions include eliminating prior authorization requirements for transfers while establishing strict timelines and reimbursement for administrative delays during appeals. This bill updates existing Medicaid and insurance rules to streamline transfers to specialized pediatric care facilities.
